<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>BASF SE — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/basf-se</link>
    <description>Plain-English explanations of patents assigned to BASF SE, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 05:52:50 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/basf-se/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Antibodies That Block Tumor Necrosis Factor Alpha (TNFα)</title>
      <link>https://patentbrief.org/patent/us/6090382/humira-adalimumab</link>
      <description>This 2000 patent describes specific human antibodies designed to strongly bind and neutralize a protein called TNFα, which is linked to inflammation and autoimmune diseases.</description>
      <pubDate>Tue, 18 Jul 2000 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/6090382/humira-adalimumab</guid>
    </item>
  </channel>
</rss>
